Comparison of rosuvastatin and atorvastatin for lipid lowering in patients with type 2 diabetes mellitus: results from the URANUS study

@article{Berne2005ComparisonOR,
  title={Comparison of rosuvastatin and atorvastatin for lipid lowering in patients with type 2 diabetes mellitus: results from the URANUS study},
  author={Christian Berne and Annica Siewert-Delle},
  journal={Cardiovascular Diabetology},
  year={2005},
  volume={4},
  pages={7 - 7}
}
OBJECTIVE The Use of Rosuvastatin versus Atorvastatin iN type 2 diabetes mellitUS (URANUS) study compared rosuvastatin with atorvastatin for the reduction of low-density lipoprotein cholesterol (LDL-C) in patients with type 2 diabetes. METHODS After a 6-week dietary run-in, patients aged > or = 18 years with type 2 diabetes and LDL-C > or = 3.3 mmol/L were randomised to double-blind treatment with rosuvastatin 10 mg (n = 232) or atorvastatin 10 mg (n = 233) for 4 weeks. Doses were then… CONTINUE READING
15 Citations
48 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 15 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 48 references

Prevention of coronary heart disease in clinical practice. Recommendations of the second joint task force of European and other societies on coronary prevention

  • D Wood, G De Backer, O Faergeman, I Graham, G Mancia, K Pyörälä
  • Eur Heart J
  • 1998
Highly Influential
4 Excerpts

AUDIT Investigators: The AUDIT Study: regional variations in physicians attitudes to diabetic dyslipidaemia

  • JD Betteridge, LA Leiter
  • Diabetologia 2004,
  • 2004
1 Excerpt

Cardiovascular risk factors in patients with type 2 diabetes. Do we follow the guidelines

  • FJ del Canizo-Gomez, MN Moreira-Andres
  • Diabetes Res Clin Pract
  • 2004
1 Excerpt

Similar Papers

Loading similar papers…